Multiscale integration of -omic, imaging, and clinical data in biomedical informatics

IEEE Reviews in Biomedical Engineering

Volumn 5, Issue , 2012, Pages 74-87

  Phan, John H ^a   Quo, Chang F ^a   Cheng, Chihwen ^b   Wang, May Dongmei ^a  

^a Emory University   (United States)

^b GEORGIA INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

Biomedical informatics; Human Protein Atlas (HPA); multiscale biomedical data integration; personalized medicine; predictive medicine; preventive medicine; the Cancer Genome Atlas (TCGA)

Indexed keywords

BIOMEDICAL DATA INTEGRATION; BIOMEDICAL INFORMATICS; CANCER GENOME; HUMAN PROTEINS; PERSONALIZED MEDICINES; PREVENTIVE MEDICINES;

DATA ACQUISITION; DISEASES; GENES; PROTEINS;

BIOINFORMATICS;

BIOLOGY; DIAGNOSTIC IMAGING; FACTUAL DATABASE; GENETICS; HUMAN; IMAGE PROCESSING; MEDICAL INFORMATICS; METHODOLOGY; NEOPLASM; REVIEW;

COMPUTATIONAL BIOLOGY; DATABASES, FACTUAL; DIAGNOSTIC IMAGING; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MEDICAL INFORMATICS; NEOPLASMS;

EID: 84871015639     PISSN: 19373333     EISSN: None     Source Type: Journal    
DOI: 10.1109/RBME.2012.2212427     Document Type: Review

References (114)

1. P. J. Hunter and M. Viceconti, "The VPH-physiome project: Standards and tools for multiscale modeling in clinical applications," IEEE Rev. Biomed. Eng., vol. 2, pp. 40-53, 2009.
2. M. E. Straver, A.M. Glas, J. Hannemann, J.Wesseling, M. J. van de Vijver, E. J. T. Rutgers,M. J. T. F. D. V. Peeters,H. vanTinteren,L. J. van 't Veer, and S. Rodenhuis, "The 70-gene signature as a response predictor for neoadjuvant chemotherapy in breast cancer," Breast Cancer Res. Treatment, vol. 119, pp. 551-558, 2010.
3. K. D. Sorensen and T. F. Orntoft, "Discovery of prostate cancer biomarkers by microarray gene expression profiling," Expert Rev. Mol. Diagn., vol. 10, pp. 49-64, 2010.
4. G. Bratslavsky, T. Sanford, R. Srinivasan, O. Aprelikova, J. Liu, M. Quezado, M. Merino, and W. M. Linehan, "Differential genetic expression in large versus small clear cell renal cell carcinoma: Results from microarray analysis," J. Cancer, vol. 2, pp. 271-279, 2011.
5. I. J. Majewski and R. Bernards, "Taming the dragon: Genomic biomarkers to individualize the treatment of cancer," Nat. Med., vol. 17, pp. 304-312, 2011.
6. T. Barrett, D. B. Troup, S. E. Wilhite, P. Ledoux, C. Evangelista, I. F. Kim, M. Tomashevsky, K. A. Marshall, K. H. Phillippy, and P. M. Sherman, "NCBI GEO: Archive for functional genomics data sets-10 years on," Nucleic Acids Res., vol. 39, pp. D1005-D1010, 2011.
7. R. Leinonen, H. Sugawara, and M. Shumway, "The sequence read archive," Nucleic Acids Research, vol. 39, pp. D19-D21, 2011.
8. J. Quackenbush, "Microarray analysis and tumor classification," N. Engl. J. Med., vol. 354, pp. 2463-2472, 2006.
9. M. J. Heller, "DNA microarray technology: Devices, systems, and applications," Annu. Rev. Biomed. Eng., vol. 4, pp. 129-153, 2002.
10. A. Schulze and J. Downward, "Navigating gene expression using microarrays-A technology review," Nature Cell Biol., vol. 3, pp. E190-E195, 2001.
11. M. L. Metzker, "Sequencing technologies-The next generation," Nat. Rev. Genet., vol. 11, pp. 31-46, 2009.
12. Z.Wang, M. Gerstein, and M. Snyder, "RNA-Seq: A revolutionary tool for transcriptomics," Nat. Rev. Genet., vol. 10, pp. 57-63, 2009.
13. I. P. Gorlov, G. E. Gallick, O. Y. Gorlova, C. Amos, and C. J. Logothetis, "GWAS meets microarray: Are the results of genome-wide association studies and gene-expression profiling consistent? Prostate cancer as an example," PLoS One, vol. 4, pp. e6511-e6511, 2009.
14. L. Luo, E. Boerwinkle, and M. Xiong, "Association studies for nextgeneration sequencing," Genome Res., vol. 21, pp. 1099-1108, 2011.
15. M. A. Van De Wiel, F. Picard, W. N. Van Wieringen, and B. Ylstra, "Preprocessing and downstream analysis of microarray DNA copy number profiles," Briefings in Bioinformatics, vol. 12, pp. 10-21, 2011.
16. C. Alkan, J. M. Kidd, T. Marques-Bonet, G. Aksay, F. Antonacci, F. Hormozdiari, J. O. Kitzman, C. Baker, M. Malig, and O. Mutlu, "Personalized copy number and segmental duplication maps using next-generation sequencing," Nature Genetics, vol. 41, pp. 1061-1067, 2009.
17. J. Sandoval, H. A. Heyn, S. Moran, J. Serra-Musach, M. A. Pujana, M. Bibikova, and M. Esteller, "Validation of a DNA methylation microarray for 450,000 CpG sites in the human genome," Epigenetics: Official J. DNA Methylation Soc., vol. 6, 2011.
18. J. Deng, R. Shoemaker, B. Xie, A. Gore, E. M. LeProust, J. Antosiewicz-Bourget, D. Egli, N. Maherali, I. H. Park, and J. Yu, "Targeted bisulfite sequencing reveals changes in DNA methylation associated with nuclear reprogramming," Nature Biotechnol., vol. 27, pp. 353-360, 2009.
19. F. Sato, S. Tsuchiya, K. Terasawa, and G. Tsujimoto, "Intra-platform repeatability and inter-platform comparability of microRNA microarray technology," PLoS One, vol. 4, pp. e5540-e5540, 2009.
20. H. P. J. Buermans, Y. Ariyurek, G. van Ommen, J. T. den Dunnen, and P. A. Hoen, "New methods for next generation sequencing based expression profiling," BMC Genomics, vol. 11, pp. 716-716, 2010.
21. M. Gstaiger and R. Aebersold, "Applying mass spectrometry-based proteomics to genetics, genomics and network biology," Nat. Rev. Genet., vol. 10, pp. 617-627, 2009.
22. T. Nilsson, M. Mann, R. Aebersold, J. R. Yates, A. Bairoch, and J. J.M. Bergeron, "Mass spectrometry in high-throughput proteomics: Ready for the big time," Nature Methods, vol. 7, pp. 681-681, 2010.
23. J. R. Yates, C. I. Ruse, and A. Nakorchevsky, "Proteomics by mass spectrometry: Approaches, advances, and applications," Annu. Rev. Biomed. Eng., vol. 11, pp. 49-79, 2009.
24. N. Ramachandran, J. V. Raphael, E. Hainsworth, G. Demirkan, M. G. Fuentes,A. Rolfs,Y. Hu, and J. LaBaer, "Next-generation high-density self-assembling functional protein arrays," Nature Methods, vol. 5, pp. 535-538, 2008.
25. M. E. Hudson, I. Pozdnyakova, K. Haines, G. Mor, and M. Snyder, "Identification of differentially expressed proteins in ovarian cancer using high-density protein microarrays," Proc. Nat. Acad. Sci., vol. 104, pp. 17494-17494, 2007.
26. G. Novara, G. Martignoni, W. Artibani, and V. Ficarra, "Grading systems in renal cell carcinoma," J. Urol., vol. 177, pp. 430-436, 2007.
27. P. A. Humphrey, "Gleason grading and prognostic factors in carcinoma of the prostate," Modern Pathol., vol. 17, pp. 292-306, 2004.
28. A. Malpica, M. T. Deavers, K. Lu, D. C. Bodurka, E. N. Atkinson, D. M. Gershenson, and E. G. Silva, "Grading ovarian serous carcinoma using a two-tier system," Amer. J. Surgical Pathol., vol. 28, pp. 496-496, 2004.
29. L. A. D. Cooper, J. Kong, D. A. Gutman, F.Wang, J. Gao, C. Appin, S. Cholleti, T. Pan, A. Sharma, and L. Scarpace, "Integrated morphologic analysis for the identification and characterization of disease subtypes," J. Amer. Med. Informatics Assoc., vol. 19, pp. 317-323, 2012.
30. U. Resch-Genger, M. Grabolle, S. Cavaliere-Jaricot, R. Nitschke, and T. Nann, "Quantum dots versus organic dyes as fluorescent labels," Nat. Methods, vol. 5, pp. 763-775, 2008.
31. X. Gao, Y. Cui, R. M. Levenson, L. W. K. Chung, and S. Nie, "Vivo cancer targeting and imaging with semiconductor quantum dots," Nature Biotechnol., vol. 22, pp. 969-976, 2004.
32. E. Tholouli, E. Sweeney, E. Barrow, V. Clay, J. A. Hoyland, and R. J. Byers, "Quantum dots light up pathology," J. Pathol., vol. 216, pp. 275-285, 2008.
33. F. Pinaud, S. Clarke, A. Sittner, and M. Dahan, "Probing cellular events, one quantum dot at a time," Nature Methods, vol. 7, pp. 275-285, 2010.
34. P. T. K. Chin, T. Buckle, A. A. de Miguel, S. C. J. Meskers, R. A. J. Janssen, and F. W. B. van Leeuwen, "Dual-emissive quantum dots for multispectral intraoperative fluorescence imaging," Biomaterials, vol. 31, pp. 6823-6832, 2010.
35. K. Schwamborn and R. M. Caprioli, "Molecular imaging by mass spectrometry-Looking beyond classical histology," Nat. Rev. Cancer, vol. 10, pp. 639-646, 2010.
36. K. Chughtai and R. M. A. Heeren, "Mass spectrometric imaging for biomedical tissue analysis," Chem. Rev., vol. 110, pp. 3237-3237, 2010.
37. M. Uhlen, P. Oksvold, L. Fagerberg, E. Lundberg, K. Jonasson, M. Forsberg, M. Zwahlen, C. Kampf, K. Wester, and S. Hober, "Towards a knowledge-based human protein atlas," Nat. Biotechnol., vol. 28, pp. 1248-1250, 2010.
38. R. McLendon, A. Friedman, D. Bigner, E. G. Van Meir, D. J. Brat, G. M. Mastrogianakis, J. J. Olson, T. Mikkelsen, N. Lehman, and K. Aldape, "Comprehensive genomic characterization defines human glioblastoma genes and core pathways," Nature, vol. 455, pp. 1061-1068, 2008.
39. D. Bell, A. Berchuck, M. Birrer, J. Chien, D. Cramer, F. Dao, R. Dhir, P. Disaia, H. Gabra, and P. Glenn, "Integrated genomic analyses of ovarian carcinoma," Nature, vol. 474, pp. 609-615, 2011.
40. L. V. Rasmussen, P. L. Peissig, C. A. McCarty, and J. Starren, "Development of an optical character recognition pipeline for handwritten form fields from an electronic health record," J. Amer. Med. Informatics Assoc., 2011.
41. A. K. Jha, C. M. DesRoches, E. G. Campbell, K. Donelan, S. R. Rao, T. G. Ferris, A. Shields, S. Rosenbaum, and D. Blumenthal, "Use of electronic health records in US hospitals," N. Engl. J. Medicine, vol. 360, pp. 1628-1638, 2009.
42. R. H. Dolin, L. Alschuler, S. Boyer, C. Beebe, F. M. Behlen, P. V. Biron, and A. S. Shvo, "HL7 clinical document architecture, release 2," J. Amer. Med. Informatics Assoc., vol. 13, pp. 30-39, 2006.
43. I. Hrynaszkiewicz, M. L. Norton, A. J. Vickers, and D. G. Altman, "Preparing raw clinical data for publication: Guidance for journal editors, authors, and peer reviewers," BMJ (CR)-Print, vol. 340, pp. 181-181, 2010.
44. D. L. Cao, D. W. Ye, H. L. Zhang, Y. Zhu, Y. X. Wang, and X. D. Yao, "A multiplex model of combining gene-based, protein-based, and metabolite-based with positive and negative markers in urine for the early diagnosis of prostate cancer," The Prostate, vol. 71, pp. 700-710, 2011.
45. W. H. Chow, L. M. Dong, and S. S. Devesa, "Epidemiology and risk factors for kidney cancer," Nature Rev. Urol., vol. 7, pp. 245-257, 2010.
46. T. Rajkumar, N. Vijayalakshmi, K. Sabitha, S. Shirley, G. Selvaluxmy, M. V. Bose, and L. Nambaru, "A 7 gene expression score predicts for radiation response in cancer cervix," BMC Cancer, vol. 9, pp. 365-365, 2009.
47. R. Salazar, P. Roepman, G. Capella, V. Moreno, I. Simon, C. Dreezen, A. Lopez-Doriga, C. Santos, C. Marijnen, and J. Westerga, "Gene expression signature to improve prognosis prediction of stage II and III colorectal cancer," J. Clin. Oncol., vol. 29, pp. 17-24, 2011.
48. A. Buhmeida, S. Pyrhonen, M. Laato, and Y. Collan, "Prognostic factors in prostate cancer," Diagn. Pathol., vol. 1, pp. 124-124, 2006.
49. S. L. Cohn, A. D. J. Pearson, W. B. London, T.Monclair, P. F. Ambros, G. M. Brodeur, A. Faldum, B. Hero, T. Iehara, and D. Machin, "The InternationalNeuroblastoma Risk Group (INRG) classification system: An INRG task force report," J. Clin.Oncol., vol. 27, pp. 289-297, 2009.
50. G. Thanassoulis and R. S. Vasan, "Genetic cardiovascular risk prediction will we get there," Circulation, vol. 122, pp. 2323-2334, 2010.
51. J. H. Phan, R. A.Moffitt, T. H. Stokes, J. Liu, A. N. Young, S. Nie, and M. D. Wang, "Convergence of biomarkers, bioinformatics and nanotechnology for individualized cancer treatment," Trends Biotechnol., vol. 27, pp. 350-358, Jun. 2009.
52. A. C. Culhane, M. S. Schröder, R. Sultana, S. C. Picard, E. N. Martinelli, C. Kelly, B. Haibe-Kains, M. Kapushesky, A. A. S. Pierre, and W. Flahive, "GeneSigDB: A manually curated database and resource for analysis of gene expression signatures," Nucleic Acids Res., vol. 40, pp. D1060-D1066, 2012.
53. M. Kapushesky, T. Adamusiak, T. Burdett, A. Culhane, A. Farne, A. Filippov, E. Holloway, A. Klebanov, N. Kryvych, and N. Kurbatova, "Gene Expression Atlas update-A value-added database of microarray and sequencing-based functional genomics experiments," Nucleic Acids Res., 2011.
54. P. A. Futreal, L. Coin, M. Marshall, T. Down, T. Hubbard, R.Wooster, N. Rahman, and M. R. Stratton, "A census of human cancer genes," Nature Rev. Cancer, vol. 4, pp. 177-183, 2004.
55. C. Schueller, A. Fritz, S. Torres, K.Wenger, K. Albermann, G. Komatsoulis, P. Covitz, L. Wright, and F. Hartel, "Towards a comprehensive catalog of gene-disease and gene-drug relationships in cancer," in Proc. Int. Conf. Intelligent Systems forMolecular Biology, Detroit,MI, 2005.
56. N. Sioutos, S. Coronado, M. Haber, F. Hartel,W. Shaiu, and L.Wright, "NCI thesaurus: A semantic model integrating cancer-related clinical and molecular information," J. Biomed. Inform., vol. 40, pp. 30-43, 2007.
57. M.Harris, J. Clark, A. Ireland, J. Lomax, M.Ashburner,R. Foulger, K. Eilbeck, S. Lewis, B. Marshall, and C. Mungall, "The Gene Ontology (GO) database and informatics resource," Nucleic Acids Res., vol. 32, pp. D258-D261, 2004.
58. S. Carbon, A. Ireland, C. J.Mungall, S. Shu, B. Marshall, and S. Lewis, "AmiGO: Online access to ontology and annotation data," Bioinformatics, vol. 25, pp. 288-289, Jan. 2009.
59. P. C. Carvalho, J. S. G. Fischer, E. I. Chen,G. B.Domont, M. G. C. Carvalho, W. M. Degrave, J. R. Yates, and V. C. Barbosa, "GO explorer: A gene-ontology tool to aid in the interpretation of shotgun proteomics data," Proteome Sci., vol. 7, pp. 6-6, 2009.
60. D. Binns, E. Dimmer, R. Huntley, D. Barrell, C. O'Donovan, and R. Apweiler, "QuickGO: A web-based tool for Gene Ontology searching," Bioinformatics, vol. 25, pp. 3045-3045, 2009.
61. D. Natale, C. Arighi,W. Barker, J. Blake, T. Chang, Z. Hu, H. Liu, B. Smith, and C. Wu, "Framework for a protein ontology," BMC Bioinformat., vol. 8, pp. S1-S1, 2007.
62. B. Smith, M. Ashburner, C. Rosse, J. Bard,W. Bug,W. Ceusters, L. J. Goldberg, K. Eilbeck, A. Ireland, and C. J. Mungall, "The OBO Foundry: Coordinated evolution of ontologies to support biomedical data integration," Nature Biotechnol., vol. 25, pp. 1251-1255, 2007.
63. E. Gadaleta, N. R. Lemoine, and C. Chelala, "Online resources of cancer data: Barriers, benefits and lessons," Brief. Bioinformat., vol. 12, pp. 52-63, 2011.
64. W. J. Lin, H. M. Hsueh, and J. J. Chen, "Power and sample size estimation in microarray studies," BMC Bioinformat., vol. 11, 2010.
65. A. Campain and Y. Yang, "Comparison study of microarray meta-analysis methods," BMC Bioinformat., vol. 11, pp. 408-408, 2010.
66. E. Freyhult, M. Landfors, J. Önskog, T. Hvidsten, and P. Rydén, "Challenges in microarray class discovery: A comprehensive examination of normalization, gene selection and clustering," BMC Bioinformat., vol. 11, pp. 503-503, 2010.
67. M. Reimers, "Making informed choices about microarray data analysis," PLoS Computational Biol., vol. 6, pp. e1000786-e1000786, 2010.
68. W. K. Lim, K.Wang, C. Lefebvre, and A. Califano, "Comparative analysis of microarray normalization procedures: Effects on reverse engineering gene networks," Bioinformat., vol. 23, pp. i282-i288, 2007.
69. R. Irizarry, D. Warren, F. Spencer, I. Kim, S. Biswal, B. Frank, E. Gabrielson, J. Garcia, J. Geoghegan, and G. Germino, "Multiple-laboratory comparison of microarray platforms," Nat. Methods, vol. 2, pp. 345-350, 2005.
70. P. Stafford andM. Brun, "Three methods for optimization of cross-laboratory and cross-platform microarray expression data," Nucleic Acids Res., vol. 35, pp. e72-e72, 2007.
71. A. N. Schuetz, Q. Yin-Goen, M. B. Amin, C. S. Moreno, C. Cohen, C. D. Hornsby, W. L. Yang, J. A. Petros, M. M. Issa, J. G. Pattaras, K. Ogan, F. F. Marshall, and A. N. Young, "Molecular classification of renal tumors by gene expression profiling," J. Mol. Diagn., vol. 7, pp. 206-218, 2005.
72. J. Jones, H. Otu, D. Spentzos, S. Kolia, M. Inan, W. D. Beecken, C. Fellbaum, X. Gu, M. Joseph, A. J. Pantuck, D. Jonas, and T. A. Libermann, "Gene signatures of progression and metastasis in renal cell cancer," Clin. Cancer Res., vol. 11, pp. 5730-5739, Aug. 2005.
73. E. Kort, L. Farber, M. Tretiakova, D. Petillo, K. Furge, X. Yang, A. Cornelius, andB. Teh, "TheE2f3-oncomir-1 axis is activated inWilms' tumor," Cancer Res., vol. 68, pp. 4034-4038, 2008.
74. M. Yusenko, R. Kuiper, T. Boethe, B. Ljungberg, A. van Kessel, and G. Kovacs, "High-resolution DNA copy number and gene expression analyses distinguish chromophobe renal cell carcinomas and renal oncocytomas," BMC Cancer, vol. 9, pp. 152-152, 2009.
75. J. Higgins, R. Shinghal, H. Gill, J. Reese,M. Terris, R. Cohen,M. Fero, J. Pollack, M. Van De Rijn, and J. Brooks, "Gene expression patterns in renal cell carcinoma assessed by complementary DNA microarray," Amer. J. Pathol., vol. 162, pp. 925-932, 2003.
76. W. P. Kuo, F. Liu, J. Trimarchi, C. Punzo, M. Lombardi, J. Sarang, M. E. Whipple, M. Maysuria, K. Serikawa, and S. Y. Lee, "A sequence-oriented comparison of gene expression measurements across different hybridization-based technologies," Nature Biotechnol., vol. 24, pp. 832-840, 2006.
77. H. Li and R. Durbin, "Fast and accurate short read alignment with Burrows-Wheeler transform," Bioinformat., vol. 25, pp. 1754-1760, 2009.
78. C. Chen, K. Grennan, J. Badner, D. Zhang, E. Gershon, L. Jin, and C. Liu, "Removing batch effects in analysis of expression microarray data: An evaluation of six batch adjustment methods," PloS One, vol. 6, pp. e17238-e17238, 2011.
79. W. Johnson, C. Li, and A. Rabinovic, "Adjusting batch effects in microarray expression data using empirical Bayes methods," Biostatistics, vol. 8, pp. 118-127, 2007.
80. B. Bolstad, R. Irizarry, M. Astrand, and T. Speed, "A comparison of normalization methods for high density oligonucleotide array data based on variance and bias," Bioinformatics, vol. 19, pp. 185-193, 2003.
81. L. Lusa, L. McShane, J. Reid, L. De Cecco, F. Ambrogi, E. Biganzoli, M. Gariboldi, and M. Pierotti, "Challenges in projecting clustering results across gene expression-profiling datasets," J. Nat. Cancer Inst., vol. 99, pp. 1715-1723, 2007.
82. T. Park, S. Yi, Y. Shin, and S. Lee, "Combining multiple microarrays in the presence of controlling variables," Bioinformatics, vol. 22, pp. 1682-1689, 2006.
83. J. Choi, U. Yu, S. Kim, and O. Yoo, "Combining multiple microarray studies and modeling interstudy variation," Bioinformatics, vol. 19, pp. i84-i90, 2003.
84. R. Breitling and P. Herzyk, "Rank-based methods as a non-parametric alternative of the T-statistic for the analysis of biological microarray data," J. Bioinform. Comput. Biol., vol. 3, pp. 1171-1190, 2005.
85. A. Brazma, "Minimum information about a microarray experiment (MIAME)-Successes, failures, challenges," Scientific World J., vol. 9, pp. 420-423, 2009.
86. H. Parkinson, M. Kapushesky, N. Kolesnikov, G. Rustici, M. Shojatalab, N. Abeygunawardena, H. Berube, M. Dylag, I. Emam, and A. Farne, "ArrayExpress update-From an archive of functional genomics experiments to the atlas of gene expression," Nucleic Acids Res., vol. 37, pp. D868-D872, 2009.
87. T. Barrett, D. B. Troup, S. E.Wilhite, P. Ledoux, D. Rudnev, C. Evangelista, I. F. Kim, A. Soboleva,M. Tomashevsky, and K. A. Marshall, "NCBI GEO: Archive for high-throughput functional genomic data," Nucleic Acids Res., vol. 37, pp. D885-D890, 2009.
88. T. Rayner, P. Rocca-Serra, P. Spellman, H. Causton, A. Farne, E. Holloway, R. Irizarry, J. Liu, D. Maier, and M. Miller, "A simple spreadsheet-based, MIAME-supportive format for microarray data: MAGETAB," BMC Bioinformat., vol. 7, pp. 489-489, 2006.
89. A. Tabesh, M. Teverovskiy, P. Ho-Yuen, V. P. Kumar, D. Verbel, A. Kotsianti, and O. Saidi, "Multifeature prostate cancer diagnosis and Gleason grading of histological images," IEEE Trans.Med. Imag., vol. 26, no. 6, pp. 1366-1378, Jun. 2007.
90. S. Kothari, J. H. Phan, A. N. Young, and M. D. Wang, "Histological image feature mining reveals emergent diagnostic properties for renal cancer," in Proc. IEEE Int. Conf. Bioinformat. Biomedicine (BIBM), 2011.
91. T. Fuchs, P. Wild, H. Moch, and J. Buhmann, "Computational pathology analysis of tissue microarrays predicts survival of renal clear cell carcinoma patients," Lecture Notes in Computer Science, vol. 5242, pp. 1-8, 2008.
92. M. Rahman, P. Bhattacharya, and B. C. Desai, "A framework for medical image retrieval using machine learning and statistical similarity matching techniques with relevance feedback," IEEE Trans. Info. Technol. Biomedicine, vol. 11, pp. 58-69, 2007.
93. C.Meurie, G. Lebrun, O. Lezoray, and A. Elmoataz, "A comparison of supervised pixels-based color image segmentation methods. Application in cancerology," WSEAS Trans. Computers, vol. 2, pp. 739-744, 2003.
94. K. Mao, P. Zhao, and P. Tan, "Supervised learning-based cell image segmentation for P53 immunohistochemistry," IEEE Trans. Biomed. Eng., vol. 53, no. 5, pp. 1153-1163, May 2006.
95. P. Ranefalla, L. Egevadb, B. Nordina, and E. Bengtssona, "A new method for segmentation of colour images applied to immunohistochemically stained cell nuclei," Analytical Cellular Pathol., vol. 15, pp. 145-156, 1997.
96. S. Kothari, J. H. Phan, R. A. Moffitt, T. H. Stokes, S. E. Hassberger, Q. Chaudry, A. N. Young, and M. D. Wang, "Automatic batchinvariant color segmentation of histological cancer images," in Proc. IEEE Int. Symp. Biomedical Imaging: From Nano to Macro, 2011, pp. 657-660.
97. M.Macenko,M. Niethammer, J. S.Marron, D.Borland, J. T. Woosley, G. Xiaojun, C. Schmitt, and N. E. Thomas, "A method for normalizing histology slides for quantitative analysis," in Proc. IEEE Int. Symp. Biomedical Imaging: From Nano to Macro, 2009, pp. 1107-1110.
98. D. Magee, D. Treanor, D. Crellin, M. Shires, K. Smith, K. Mohee, and P. Quirke, "Colour normalisation in digital histopathology images," in Proc. Optical Tissue Image Analysis Microscopy, Histopathology and Endoscopy (MICCAI Workshop), 2009, pp. 100-111.
99. S. Mukherjee and S. Roberts, "A theoretical analysis of the selection of differentially expressed genes," J. Bioinform. Comput. Biol., vol. 3, pp. 627-644, 2005.
100. L. Chen, J. Xuan, C. Wang, I. Shih, Y. Wang, Z. Zhang, E. Hoffman, and R. Clarke, "Knowledge-guided multi-scale independent component analysis for biomarker identification," BMC Bioinformat., vol. 9, 2008.
101. J. Phan, Q. Yin-Goen, A. Young, and M. Wang, "Improving the efficiency of biomarker identification using biological knowledge," in Proc. Symp. Biocomput., 2009, pp. 427-438.
102. V. Tusher, R. Tibshirani, and G. Chu, "Significance analysis of microarrays applied to the ionizing radiation response," Proc. Nat. Acad. Sci. USA, vol. 98, pp. 5116-5121, 2001.
103. C. Ding and H. Peng, "Minimum redundancy feature selection from microarray gene expression data," J. Bioinform. Comput. Biol., vol. 3, pp. 185-206, 2005.
104. M. Uhlen, P. Oksvold, L. Fagerberg, E. Lundberg, K. Jonasson, M. Forsberg, M. Zwahlen, C. Kampf, K. Wester, and S. Hober, "Towards a knowledge-based human protein atlas," Nature Biotechnol., vol. 28, pp. 1248-1250, 2010.
105. L. Berglund, E. Björling, P. Oksvold, L. Fagerberg, A. Asplund, C. A. K. Szigyarto, A. Persson, J. Ottosson, H. Wernérus, and P. Nilsson, "A genecentric human protein atlas for expression profiles based on antibodies," Molecular Cellular Proteomics, vol. 7, pp. 2019-2027, 2008.
106. R. G. W. Verhaak, K. A. Hoadley, E. Purdom, V. Wang, Y. Qi, M. D. Wilkerson, C. R. Miller, L. Ding, T. Golub, and J. P. Mesirov, "Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1," Cancer Cell, vol. 17, pp. 98-110, 2010.
107. D. Bell, A. Berchuck, M. Birrer, J. Chien, D. Cramer, F. Dao, R. Dhir, P. Disaia, H. Gabra, and P. Glenn, "Integrated genomic analyses of ovarian carcinoma," Nature, vol. 474, pp. 609-615, 2011.
108. C. J. Creighton, A. Hernandez-Herrera, A. Jacobsen, D. A. Levine, P. Mankoo, N. Schultz, Y. Du, Y. Zhang, E. Larsson, and R. Sheridan, "Integrated analyses of microRNAs demonstrate their widespread influence on gene expression in high-grade serous ovarian carcinoma," PloS One, vol. 7, pp. e34546-e34546, 2012.
109. K. Shinjo, Y. Okamoto, B. An, T. Yokoyama, I. Takeuchi, M. Fujii, H. Osada, N. Usami, Y. Hasegawa, and H. Ito, "Integrated analysis of genetic and epigenetic alterations reveals CpG island methylator phenotype associated with distinct clinical characters of lung adenocarcinoma," Carcinogenesis, 2012.
110. F. Wang, J. Kong, L. Cooper, T. Pan, T. Kurc, W. Chen, A. Sharma, C. Niedermayr, T.W. Oh, and D. Brat, "A data model and database for high-resolution pathology analytical image informatics," J. Pathology Informatics, vol. 2, 2011.
111. H. Thorvaldsdóttir, J. T. Robinson, and J. P. Mesirov, "Integrative genomics viewer (IGV): High-performance genomics data visualization and exploration," Brief. Bioinformat., 2012.
112. Q. Cheng, J. T. Chang, J. Geradts, L. M. Neckers, T. Haystead, N. Spector, and H. K. Lyerly, "Amplification and high-level expression of heat shock protein 90 marks aggressive phenotypes of human epidermal growth factor receptor 2 negative breast cancer," Breast Cancer Res., vol. 14, pp. R62-R62, 2012.
113. Y. Xiao, P. A. Decker, T. Rice, L. S. McCoy, I. Smirnov, J. Patoka, H. M. Hansen, J. L. Wiemels, T. Tihan, and M. D. Prados, "SSBP2 variants are associated with survival in glioblastoma patients," Clin. Cancer Res., 2012.
114. R. Shen, Q. Mo, N. Schultz, V. E. Seshan, A. B. Olshen, J. Huse, M. Ladanyi, and C. Sander, "Integrative subtype discovery in glioblastoma using iCluster," PloS One, vol. 7, pp. e35236-e35236, 2012.